In the dynamic and highly regulated world of healthcare supply chain, requesting a new product — whether it’s a cutting-edge surgical instrument, a specialized vascular catheter, or an IV item for clinical floors — is never a simple purchasing decision. Instead, it’s a complex, multifaceted process with dramatic implications for patient safety, clinical efficacy, and financial health.
The sheer volume of new requests from clinicians, driven by advancements in medical science and aggressive vendor marketing, can be overwhelming. Without a rigorous, systematic process for evaluating these new product requests, a healthcare system risks fragmentation, financial distress, and, most critically, compromised patient care. While every health system has its own unique governance structure and workflow, the argument for adherence to a standardized, methodical process remains absolute.
The Risks of Circumventing the VA Process
Ignoring or circumventing the established value analysis evaluation process, regardless of how well-intentioned the requesting (internal or external) party may be, opens the door to several significant risks:
- Financial Waste and Escalation: A product’s initial purchase price is often only the tip of the iceberg. Hidden costs, such as maintenance contracts, specialized training, and required disposable accessories, can quickly inflate the total cost of ownership (TCO). Without systematic review by supply chain and finance teams, products may be approved that offer minimal clinical benefit at an exorbitant cost, diverting resources from other critical areas.
- Clinical Inconsistency and Risk: When individual departments or physicians introduce products ad-hoc, it leads to a fragmented clinical environment. Different units may use different versions of the same product or entirely disparate products for the same procedure. This lack of standardization can confuse staff, increase the risk of errors, complicate training, and make it difficult to aggregate data on outcomes.
- Lack of Evidence-Based Adoption: True innovation is grounded in clinical evidence. An unsystematic process can allow product champions to push for adoption based on anecdotal success or personal preference, rather than robust, peer-reviewed data. A systematic process forces a critical review of the evidence, ensuring that new products offer a demonstrable improvement in safety, quality, or efficiency over existing alternatives.
- Regulatory and Compliance Failure: Healthcare is heavily regulated. The adoption of new products often necessitates compliance with accreditation standards (like The Joint Commission), state and federal regulations, and internal risk management policies. A skipped step in the approval process could lead to non-compliance, resulting in fines, loss of accreditation, or legal liability.
- Inventory and Supply Chain Chaos: Uncontrolled product proliferation complicates inventory management. It leads to a bloated formulary, increased stockouts of critical items, and a higher risk of expiring products. A systematic process helps standardize products, leading to better contract leverage, optimized inventory levels, and a more resilient supply chain.
VA systems flow using a systematic, evidence-based process that covers all of the bases for a successful product introduction and/or replacement by dotting all the “I’s” and crossing all the “T’s” quickly and easily. But if your end users continually omit key data, what do they expect will happen to their new product requests? When necessary, information needs to be obtained.
It may appear to be a complex process for your end users to submit new product requests, but they need to realize that it is necessary for them to follow the process. In essence, the process is the shortcut for them to get the new product or service that they want faster – but they need to have all the necessary information submitted every time.
The bottom line is, it is worth the time to educate everyone from your department heads/managers to your physicians and even your sales representatives in your value analysis process to give a new level of understanding which will only make your workflow move faster for all. Just creating the best value analysis new product evaluation process is only part of the game. You need to continually educate your customers and stakeholders, so they understand your system upstream and downstream.
Below are some similar articles that you may find interesting.
The Upside Potential with Healthcare Value Analysis in 2025 and Beyond
What You Need to Do If You Are Called Upon to Lead a Health System-Wide Cost Reduction Program